Skip to main navigation menu Skip to main content Skip to site footer

An Approach To:

Vol. 20 No. 2 (2022): New Horizons: Innovation in Medicine

Approach to Hypercalcemia

DOI
https://doi.org/10.26443/mjm.v20i2.941
Submitted
September 19, 2021
Published
2022-04-19

Abstract

Hypercalcemia is a presentation commonly encountered in the clinical setting. Due to its vast differential diagnosis, a systematic approach is necessary when approaching patients with hypercalcemia. This article presents a simple, yet thorough approach to help clinicians determine the etiology of their patients' hypercalcemia. The main components of history taking, physical examination, and laboratory investigations for patients with hypercalcemia are highlighted. Emphasis is put on the importance of determining whether the hypercalcemia is associated with elevated or inappropriately normal parathyroid hormone (PTH) levels or not. The main etiologies of PTH-dependent hypercalcemia and PTH-independent hypercalcemia are explored. Primary hyperparathyroidism and hypercalcemia secondary to malignancy are highlighted as together, they make up 90% of hypercalcemia cases. A presentation of the management principles of hypercalcemia is also provided.

References

  1. Minisola S, Pepe J, Piemonte S, Cipriani C. The diagnosis and management of hypercalcaemia. BMJ : British Medical Journal. 2015;350:h2723. doi: 10.1136/bmj.h2723
  2. Melmed S, Williams RH. Williams textbook of endocrinology. 12th ed. Philadelphia: Elsevier/Saunders; 2011.
  3. Carroll MF, Schade DS. A practical approach to hypercalcemia. American family physician. 2003;67(9):1959-66.
  4. McCormack JP, Holmes DT. Your results may vary: the imprecision of medical measurements. BMJ. 2020;368:m149.
  5. Jameson JL, Kasper DL, Longo DL, Fauci AS, Hauser SL, Loscalzo J. Harrison's principles of internal medicine. 20th edition. ed. New York: McGraw-Hill Education; 2018.
  6. Reagan P, Pani A, Rosner MH. Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2014;63(1):141-7. doi:10.1053/j.ajkd.2013.06.025
  7. Zagzag J, Hu MI, Fisher SB, Perrier ND. Hypercalcemia and cancer: Differential diagnosis and treatment. CA Cancer J Clin. 2018;68(5):377-86. doi: 10.3322/caac.21489
  8. Nau KC, Lewis WD. Multiple myeloma: diagnosis and treatment. Am Fam Physician. 2008;78(7):853-9.
  9. Ahn SW, Kim TY, Lee S, Jeong JY, Shim H, Han YM, et al. Adrenal insufficiency presenting as hypercalcemia and acute kidney injury. Int Med Case Rep J. 2016;9:223-6. doi: 10.2147/IMCRJ.S109840
  10. Sharma OP. Hypercalcemia in granulomatous disorders: a clinical review. Current opinion in pulmonary medicine. 2000;6(5):442-7. doi: 10.1097/00063198-200009000-00010
  11. Wermers RA, Kearns AE, Jenkins GD, Melton LJ, 3rd. Incidence and clinical spectrum of thiazide-associated hypercalcemia. Am J Med. 2007;120(10):911.e9-15. doi: 10.1016/j.amjmed.2006.07.044
  12. Toronto Notes 2020: Comprehensive Medical Reference and Review for the Medical Council of Canada Qualifying Exam (MCCQE) Part I and the United States Medical Licensing Exam (USMLE) Step II: Toronto Notes for Medical Students, Incorporated; 2020.

Downloads

Download data is not yet available.

Similar Articles

You may also start an advanced similarity search for this article.